425264005: Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2022. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

3677096012 Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

3677097015 Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg oral capsule en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4723331000005114 bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Is a	Product containing bismuth biskalcitrate and metronidazole and tetracycline (medicinal product)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bismuth biskalcitrate (substance)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has manufactured dose form	A solid single-dose form that is a shell made of gelatin or other substances. The contents of the shell may be a solid, semi-solid or liquid.	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Tetracycline (substance)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Metronidazole (substance)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has manufactured dose form	Oral dose form	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has manufactured dose form	Oral capsule	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Is a	Metronidazole-containing product in oral dose form	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Is a	Product containing tetracycline in oral dose form (medicinal product form)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength denominator value	en	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute specifies the denominator unit for the presentation strength of a product.	Capsule (unit of presentation)	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength numerator value	125	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength denominator value	en	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute specifies the denominator unit for the presentation strength of a product.	Capsule (unit of presentation)	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength numerator value	125	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute specifies the numerator unit for the presentation strength of a product.	mg	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength denominator value	en	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute specifies the denominator unit for the presentation strength of a product.	Capsule (unit of presentation)	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Tetracycline (substance)	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength numerator value	125	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Bismuth biskalcitrate (substance)	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength numerator value	140	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Metronidazole (substance)	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Metronidazole (substance)	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Metronidazole (substance)	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bismuth biskalcitrate (substance)	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Bismuth biskalcitrate (substance)	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has presentation strength numerator value	140	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Tetracycline (substance)	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	Tetracycline (substance)	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Has unit of presentation	Capsule (unit of presentation)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Tetracycline (substance)	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Metronidazole (substance)	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Bismuth biskalcitrate (substance)	false	Inferred relationship	Some	2
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Is a	Product containing bismuth biskalcitrate and metronidazole and tetracycline in oral dose form (medicinal product form)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Count of base of active ingredient	tre	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Is a	Bismuth biskalcitrate and metronidazole and tetracycline only product in oral dose form	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	Plays role	Antibacterial therapeutic role (role)	false	Inferred relationship	Some
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Metronidazole (substance)	false	Inferred relationship	Some	1
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Bismuth biskalcitrate (substance)	false	Inferred relationship	Some	3
bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	Tetracycline (substance)	false	Inferred relationship	Some	2

Inbound Relationships

Type

Active

Source

Characteristic

Refinability

Group

Reference Sets

Concept inactivation indicator reference set

REPLACED BY association reference set (foundation metadata concept)

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3677096012	Product containing precisely bismuth biskalcitrate 140 milligram and metronidazole 125 milligram and tetracycline 125 milligram/1 each conventional release oral capsule (clinical drug)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3677097015	Bismuth biskalcitrate 140 mg and metronidazole 125 mg and tetracycline 125 mg oral capsule	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
4723331000005114	bismuthbiskalcitrat 140 mg + metronidazol 125 mg + tetracyclin 125 mg kapsel	da	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	Danish module (core metadata concept)